In stage IV, the cancer has metastasized, or spread, beyond the lungs into other areas of the body. About 40 percent of NSCLC patients are diagnosed with lung cancer when they are in stage IV. The five-year survival rate for those diagnosed with stage IV lung cancer is less than 10 percent.
The five-year survival rate for people diagnosed with late-stage lung cancer that has spread (metastasized) to other areas of the body is 5 percent.
Our patient was treated as stage IV NSCLC with curative intent as a deviation from established guidelines. In the absence of other distant metastases, he was .